Eurofins Scientific SE Total Assets

Latest as of December 2025: €10.98 Billion EUR ≈ $12.84 Billion USD

Eurofins Scientific SE total assets. Based on the latest financial reports, Eurofins Scientific SE (ERF) holds total assets worth €10.98 Billion EUR (≈ $12.84 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see how much is Eurofins Scientific SE worth for the company's overall valuation and market capitalisation.

Total Assets of Eurofins Scientific SE (2002–2025)

Total assets of Eurofins Scientific SE from 2002 to 2025. This chart illustrates how Eurofins Scientific SE's total assets have evolved over time, based on quarterly financial data. See latest Eurofins Scientific SE stock price today for real-time trading data and today's change.

Eurofins Scientific SE - Asset Composition Analysis

Eurofins Scientific SE Total Assets Breakdown (December 2025)

Eurofins Scientific SE total assets breakdown as of December 2025. Eurofins Scientific SE's total assets of €10.98 Billion consist of 24.2% current assets and 75.9% non-current assets.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €251.60 Million 7.2%
Accounts Receivable €1.54 Billion 14.0%
Inventory €139.00 Million 1.3%
Property, Plant & Equipment €2.76 Billion 25.2%
Intangible Assets €690.00 Million 6.3%
Goodwill €4.66 Billion 42.4%

Asset Composition Trend (2002–2025)

This chart illustrates how Eurofins Scientific SE's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Eurofins Scientific SE's working capital to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Eurofins Scientific SE's current assets represent 24.2% of total assets in 2025, a decrease from 40.7% in 2002.
  • Cash Position: Cash and equivalents constituted 7.2% of total assets in 2025, up from -1.8% in 2002.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 48.0% of total assets, an increase from 31.0% in 2002.
  • Asset Diversification: The largest asset category is goodwill at 42.4% of total assets.

Eurofins Scientific SE Competitors by Total Assets

Key competitors of Eurofins Scientific SE based on total assets are shown below.

Company Country Total Assets
Revvity Inc.
NYSE:RVTY
USA $12.00 Billion
Wuhan Thalys Med Tech Co Ltd
SHG:603716
China CN¥1.59 Billion
JOONGANG DNM Co.Ltd
KQ:051980
Korea ₩121.79 Billion
Shanghai Rendu Biotechnology Co. Ltd. A
SHG:688193
China CN¥984.02 Million
Krsnaa Diagnostics Limited
NSE:KRSNAA
India Rs15.07 Billion
Sonic Healthcare Ltd
AU:SHL
Australia AU$16.78 Billion
Integral Diagnostics Ltd
AU:IDX
Australia AU$1.43 Billion
Australian Clinical Labs Ltd
AU:ACL
Australia AU$562.50 Million

Eurofins Scientific SE - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.09 1.16 1.48
Quick Ratio 1.03 1.09 1.39
Cash Ratio 0.33 0.29 0.00
Working Capital €223.00 Million €342.00 Million €821.80 Million

Eurofins Scientific SE - Advanced Valuation Insights

This section examines the relationship between Eurofins Scientific SE's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.28
Latest Market Cap to Assets Ratio 0.93
Asset Growth Rate (YoY) 0.9%
Total Assets €10.98 Billion
Market Capitalization $10.22 Billion USD

Valuation Analysis

Near Book Valuation: The market values Eurofins Scientific SE's assets close to their book value (0.93x), suggesting investors view the company's assets at approximately fair value.

Positive Asset Growth: Eurofins Scientific SE's assets grew by 0.9% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Eurofins Scientific SE (2002–2025)

The table below shows the annual total assets of Eurofins Scientific SE from 2002 to 2025.

Year Total Assets Change
2025-12-31 €10.98 Billion
≈ $12.84 Billion
+0.89%
2024-12-31 €10.89 Billion
≈ $12.73 Billion
0.00%
2023-12-31 €10.89 Billion
≈ $12.73 Billion
+7.98%
2022-12-31 €10.08 Billion
≈ $11.79 Billion
+8.05%
2021-12-31 €9.33 Billion
≈ $10.91 Billion
+8.83%
2020-12-31 €8.58 Billion
≈ $10.03 Billion
+9.62%
2019-12-31 €7.82 Billion
≈ $9.15 Billion
+8.57%
2018-12-31 €7.21 Billion
≈ $8.42 Billion
+23.54%
2017-12-31 €5.83 Billion
≈ $6.82 Billion
+41.24%
2016-12-31 €4.13 Billion
≈ $4.83 Billion
+11.61%
2015-12-31 €3.70 Billion
≈ $4.33 Billion
+97.52%
2014-12-31 €1.87 Billion
≈ $2.19 Billion
+25.13%
2013-12-31 €1.50 Billion
≈ $1.75 Billion
+29.15%
2012-12-31 €1.16 Billion
≈ $1.36 Billion
+7.87%
2011-12-31 €1.07 Billion
≈ $1.26 Billion
+45.97%
2010-12-31 €736.16 Million
≈ $860.65 Million
+11.66%
2009-12-31 €659.30 Million
≈ $770.79 Million
-10.18%
2008-12-31 €734.01 Million
≈ $858.13 Million
+19.93%
2007-12-31 €612.02 Million
≈ $715.52 Million
+32.95%
2006-12-31 €460.34 Million
≈ $538.18 Million
+72.95%
2005-12-31 €266.16 Million
≈ $311.17 Million
+39.99%
2004-12-31 €190.12 Million
≈ $222.28 Million
+14.20%
2003-12-31 €166.48 Million
≈ $194.63 Million
+3.88%
2002-12-31 €160.26 Million
≈ $187.36 Million
--

About Eurofins Scientific SE

PA:ERF France Diagnostics & Research
Market Cap
$18.10 Billion
€15.49 Billion EUR
Market Cap Rank
#2126 Global
#46 in France
Share Price
€88.64
Change (1 day)
-0.45%
52-Week Range
€56.74 - €89.04
All Time High
€121.25
About

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection,… Read more